IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 52
Titolo Data di pubblicazione Autore(i) File
Prevalence and Prognostic Importance of Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease 1-gen-2015 Borgarelli, M; Abbott, J.; Braz Ruivo, L.; Chiavegato, D.; Crosara, Serena; Lamb, K.; Ljungvall, I.; Poggi, M.; Santilli, R. A.; Haggstrom, J.
La malattia valvolare mitralica nel cane 1-gen-2015 Crosara, Serena; Borgarelli, Michele
Systolic arterial pressure measured simultaneously by Doppler technique, using forelimb and hindlimb, in dogs 1-gen-2015 Crosara, Serena; Borrelli, A.; Riondato, F.; Quintavalla, Cecilia; Faranda, G.; Tarducci, A.; Zanatta, R.
Aorto-septal angle and systolic murmur in apparently healthy cats: a pilot study 1-gen-2016 Crosara, Serena; Allodi, Giulia; Fabbi, Martina; Corsini, Andrea; Guazzetti, Stefano; Quintavalla, Cecilia
Corner Diagnostico di Cardiologia 1-gen-2016 Martinelli, Elisa; Crosara, Serena
Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study. 1-gen-2016 Apple, Sm; Menciotti, G; Braz Ruivo, L; Crosara, Serena; Haggstrom, J; Borgarelli, M.
Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study. 1-gen-2016 Menciotti, G.; Apple, S. M.; Braz Ruivo, L.; Crosara, Serena; Häggström, J.; Borgarelli1, M. .
Preliminary investigation of cardiovascular-renal disorders in dogs with chronic mitral valve disease 1-gen-2016 Martinelli, E.; Locatelli, C.; Bassis, S.; Crosara, Serena; Paltrinieri, S.; Scarpa, P.; Spalla, I.; Zanaboni, A. M.; Quintavalla, Cecilia; Brambilla, P.
ECG of the month 1-gen-2017 Allodi, Giulia; Crosara, Serena; Quintavalla, Cecilia
Wolbachia, doxycycline and macrocyclic lactones: New prospects in the treatment of canine heartworm disease 1-gen-2018 Kramer, L.; Crosara, Serena; Gnudi, G.; Genchi, M.; Mangia, Carlo; Viglietti, A.; Quintavalla, C.
Wolbachia, doxycycline and macrocyclic lactones: New prospects in the treatment of canine heartworm disease 1-gen-2018 Kramer, L; Crosara, S; Gnudi, G; Genchi, M; Mangia, C; Viglietti, A; Quintavalla, C
Aorto-septal angle, isolated basal septal hypertrophy and systolic murmurs in 122 cats 1-gen-2019 Crosara, S.; Allodi, G.; Guazzetti, S.; Borgarelli, M.; Corsini, A.; Quintavalla, C.
Normal aortic annulus dimensions in Boxer dogs according to sex and body weight 1-gen-2019 Claretti, M.; Quintavalla, C.; Crosara, S.; Bussadori, C.
Efficacy of imidacloprid 10%/moxidectin 2.5% spot on (Advocate®, Advantage Multi®) and doxycycline for the treatment of natural Dirofilaria immitis infections in dogs 1-gen-2019 Genchi, M.; Vismarra, A.; Lucchetti, Chiara; Viglietti, A.; Crosara, S.; Gnudi, G.; Quintavalla, C.; Schaper, R.; Kramer, L.
DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study 1-gen-2020 Borgarelli, M.; Ferasin, L.; Lamb, K.; Bussadori, C.; Chiavegato, D.; D'Agnolo, G.; Migliorini, F.; Poggi, M.; Santilli, R. A.; Guillot, E.; Garelli-Paar, C.; Toschi Corneliani, R.; Farina, F.; Zani, A.; Dirven, M.; Smets, P.; Guglielmini, C.; Oliveira, P.; Di Marcello, M.; Porciello, F.; Crosara, S.; Ciaramella, P.; Piantedosi, D.; Smith, S.; Vannini, S.; Dall'Aglio, E.; Savarino, P.; Quintavalla, C.; Patteson, M.; Silva, J.; Locatelli, C.; Baron Toaldo, M.
Effect of the sampling time on urinary electrolytes following furosemide administration in dogs with myxomatous mitral valve disease 1-gen-2021 Fidanzio, F.; Sabetti, M. C.; Crosara, S.; Mazzoldi, C.; Perissinotto, L.; Quintavalla, C.; Romito, G.; Troìa, R.; Dondi, F.
Suspected Drinking Water Poisoning in a Domestic Kitten with Methemoglobinemia 1-gen-2021 Fidanzio, Francesca; Corsini, Andrea; Spindler, KEVIN PASCAL; Crosara, Serena
The predictive value of clinical, radiographic, echocardiographic variables and cardiac biomarkers for assessing risk of the onset of heart failure or cardiac death in dogs with preclinical myxomatous mitral valve disease enrolled in the DELAY study 1-gen-2021 Borgarelli, M.; Ferasin, L.; Lamb, K.; Chiavegato, D.; Bussadori, C.; D'Agnolo, G.; Migliorini, F.; Poggi, M.; Santilli, R. A.; Guillot, E.; Garelli-Paar, C.; Toschi Corneliani, R.; Farina, F.; Zani, A.; Dirven, M.; Smets, P.; Guglielmini, C.; Oliveira, P.; Di Marcello, M.; Porciello, F.; Crosara, S.; Ciaramella, P.; Piantedosi, D.; Smith, S.; Vannini, S.; Dall'Aglio, E.; Savarino, P.; Quintavalla, C.; Patteson, M.; Silva, J.; Locatelli, C.; Baron Toaldo, M.
Predictors of reoccurrence of congestive signs within 180 days after successful treatment of the first episode of congestive heart failure in dogs with myxomatous mitral valve disease 1-gen-2021 Franchini, A.; Abbott, J. A.; Tyrrell, W.; Rosenthal, S.; Lahmers, S.; Menciotti, G.; Crosara, S.; Haggstrom, J.; Borgarelli, M.
The Longitudinal Outcome Of Canine (K9) myxomatous mitral valve disease (LOOK-Mitral registry): Baseline characteristics 1-gen-2021 Franchini, A.; Borgarelli, M.; Abbott, J. A.; Menciotti, G.; Crosara, S.; Haggstrom, J.; Lahmers, S.; Rosenthal, S.; Tyrrell, W.
Mostrati risultati da 21 a 40 di 52
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile